Columbus Instruments Oxymax CLAMS High Speed Chamb

The National Heart, Lung, and Blood Institute (NHLBI) is seeking to double the capacity of its existing Columbus Instruments Oxymax CLAMS metabolic phenotyping system by adding eight high‑speed chambers and all associated hardware, sensors, software, and integration components. This is a single‑source, non‑competitive procurement because only Columbus Instruments’ expansion components are compatible with the government‑owned system. The award will be a contract for the delivery, installation, and integration of the additional chambers to achieve a total of sixteen simultaneous mouse positions, supporting indirect calorimetry, feeding/drinking measurement, activity monitoring, and telemetry. • Solicitation ID: 75N98026Q01103 (posted 08/27/2026) • Closing date for offers: 09/04/2026 (3:00 PM EST) • Award anticipated: 09/28/2026 with a performance period through 09/27/2027 (1‑year) • Required product: Eight Oxymax CLAMS high‑speed chambers and related components, fully compatible with existing system • Delivery location: NIH, Bethesda, MD • Funding: Federal (NIH) – no set‑aside, single‑source award • Small‑business status: Open to all, but set‑aside not applied • Contact: Roxane Burkett, Contracting Officer ([email protected])